No Data
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
Earnings Preview: VKTX to Report Financial Results Post-market on October 23
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $138
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
blessings u : Viking has a promising future.
U got Fomo OP blessings u : Dr. Lian is taking $12+M as annually from that future